Mice from the OVA‐Clec9A‐TNE and CAROT treatment group that had completely rejected their tumour were rechallenged with a further subcutaneous inoculation of E0771‐Her2 tumour cells in the opposite flank after remaining tumour‐free for 60 days. Here, ERBB2 is linked to neoplasm.